The Boston Globe ranks Cubist, with Bonney '80 as CEO, as No. 1 best business
The Boston Globe‘s annual ranking of the 100 best Massachusetts businesses puts Cubist Pharmaceuticals, headed by Michael Bonney ’80, in the No. 1 spot. The story notes how the Cambridge-based firm took a chance on a failed antibiotic called daptomycin originally developed by Eli Lilly & Co. “But Cubist executives thought there still might be hope for the compound,” the story says. Renamed Cubicin, the drug is now a powerful weapon in the fight against a particularly stubborn form of bacteria and “has generated hundreds of millions of dollars in annual sales and helped transform Cubist into one of the Bay State’s best-performing firms.” (View Clip and Text)
Categories: Alumni and friends, Bates People in the News, Business and finance, Health care and medicine.